Correlation Between Santhera Pharmaceuticals and IVF Hartmann

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Santhera Pharmaceuticals and IVF Hartmann at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Santhera Pharmaceuticals and IVF Hartmann into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Santhera Pharmaceuticals Holding and IVF Hartmann Holding, you can compare the effects of market volatilities on Santhera Pharmaceuticals and IVF Hartmann and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Santhera Pharmaceuticals with a short position of IVF Hartmann. Check out your portfolio center. Please also check ongoing floating volatility patterns of Santhera Pharmaceuticals and IVF Hartmann.

Diversification Opportunities for Santhera Pharmaceuticals and IVF Hartmann

-0.82
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Santhera and IVF is -0.82. Overlapping area represents the amount of risk that can be diversified away by holding Santhera Pharmaceuticals Holdi and IVF Hartmann Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on IVF Hartmann Holding and Santhera Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Santhera Pharmaceuticals Holding are associated (or correlated) with IVF Hartmann. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of IVF Hartmann Holding has no effect on the direction of Santhera Pharmaceuticals i.e., Santhera Pharmaceuticals and IVF Hartmann go up and down completely randomly.

Pair Corralation between Santhera Pharmaceuticals and IVF Hartmann

Assuming the 90 days trading horizon Santhera Pharmaceuticals Holding is expected to under-perform the IVF Hartmann. In addition to that, Santhera Pharmaceuticals is 1.98 times more volatile than IVF Hartmann Holding. It trades about -0.16 of its total potential returns per unit of risk. IVF Hartmann Holding is currently generating about 0.2 per unit of volatility. If you would invest  14,200  in IVF Hartmann Holding on August 29, 2024 and sell it today you would earn a total of  700.00  from holding IVF Hartmann Holding or generate 4.93% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Santhera Pharmaceuticals Holdi  vs.  IVF Hartmann Holding

 Performance 
       Timeline  
Santhera Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Santhera Pharmaceuticals Holding has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Santhera Pharmaceuticals is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.
IVF Hartmann Holding 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in IVF Hartmann Holding are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, IVF Hartmann may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Santhera Pharmaceuticals and IVF Hartmann Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Santhera Pharmaceuticals and IVF Hartmann

The main advantage of trading using opposite Santhera Pharmaceuticals and IVF Hartmann positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Santhera Pharmaceuticals position performs unexpectedly, IVF Hartmann can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in IVF Hartmann will offset losses from the drop in IVF Hartmann's long position.
The idea behind Santhera Pharmaceuticals Holding and IVF Hartmann Holding pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.

Other Complementary Tools

Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Bonds Directory
Find actively traded corporate debentures issued by US companies